Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19

Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that govern the pathophysiology of different disease courses remain poorly defined. Across the spectrum of disease severity, COVID-19 impairs both innate and adaptive host immune responses by activating innate immune...

Full description

Bibliographic Details
Main Authors: Marianna Rowlands, Florencia Segal, Dominik Hartl
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
immunology
immunity
MDSC
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.697405/full

Similar Items

Similar Items